HSD17B13-IN-41
HSD17B13-IN-41 (Compound C) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) . HSD17B13-IN-41 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1].
Product Specifications
CAS Number
[1122660-25-6]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-41.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C(C2=CC=C(C3=CC=CC(O)=C3)S2)C=C1C
Molecular Formula
C17H14O2S
Molecular Weight
282.36
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human TNS1 shRNA (UAS) - Lentiviral human TNS1 shRNA (UAS) (100)